INTERNATIONAL PATENT: FIMMCYTE AG FILES APPLICATION FOR "ANTIGEN BINDING MOLECULES SELECTIVE FOR CELLULAR FIBROBLAST ACTIVATION PROTEIN (FAP) OVER SOLUBLE FAP"

GENEVA, Aug. 4 -- FIMMCYTE AG (Hochbergerstrasse 60C4057 Basel) filed a patent application (PCT/EP2025/051810) for "ANTIGEN BINDING MOLECULES SELECTIVE FOR CELLULAR FIBROBLAST ACTIVATION PROTEIN (FAP) OVER SOLUBLE FAP" on Jan 24, 2025. With publication no. WO/2025/158001, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHILAIH, Mohaned (c/o Fimmcyte AGHochbergerstrasse 60C4057 Basel)

Abstract: The present invention relates to antigen binding molecules that specifically bind cellular bound fibroblast activation protein ...